171 related articles for article (PubMed ID: 22396921)
1. Paget disease of bone - an update.
Britton C; Walsh J
Aust Fam Physician; 2012 Mar; 41(3):100-3. PubMed ID: 22396921
[TBL] [Abstract][Full Text] [Related]
2. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
3. [Optimizing therapy in Paget disease].
Füessl HS
MMW Fortschr Med; 2005 Dec; 147(51-52):32. PubMed ID: 16402704
[No Abstract] [Full Text] [Related]
4. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
Hosking D; Lyles K; Brown JP; Fraser WD; Miller P; Curiel MD; Devogelaer JP; Hooper M; Su G; Zelenakas K; Pak J; Fashola T; Saidi Y; Eriksen EF; Reid IR
J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
[TBL] [Abstract][Full Text] [Related]
5. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Krane SM
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
[No Abstract] [Full Text] [Related]
6. Paget disease of bone: therapeutic options.
Silverman SL
J Clin Rheumatol; 2008 Oct; 14(5):299-305. PubMed ID: 18838910
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D
N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834
[TBL] [Abstract][Full Text] [Related]
8. [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
MMW Fortschr Med; 2006 Jun; 148(25):60-1. PubMed ID: 16859169
[No Abstract] [Full Text] [Related]
9. Pharmacological therapy of Paget's and other metabolic bone diseases.
Hosking D
Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
[TBL] [Abstract][Full Text] [Related]
10. Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid.
Devogelaer JP; Geusens P; Daci E; Gielen E; Denhaerynck K; Macdonald K; Hermans C; Vancayzeele S; Abraham I; Boonen S
Calcif Tissue Int; 2014 Mar; 94(3):311-8. PubMed ID: 24271562
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
12. Paget disease of bone: diagnosis and drug therapy.
Seton M
Cleve Clin J Med; 2013 Jul; 80(7):452-62. PubMed ID: 23821690
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate.
Sambrook PN; Roux C; Devogelaer JP; Saag K; Lau CS; Reginster JY; Bucci-Rechtweg C; Su G; Reid DM
Bone; 2012 Jan; 50(1):289-95. PubMed ID: 22061864
[TBL] [Abstract][Full Text] [Related]
14. Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy.
Pane A
Arch Ophthalmol; 2007 Oct; 125(10):1440-1. PubMed ID: 17923566
[No Abstract] [Full Text] [Related]
15. What is the optimal duration of bisphosphonate therapy?
Ott SM
Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
[TBL] [Abstract][Full Text] [Related]
16. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
17. Going on a drug holiday?
Bonnick SL
J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
[No Abstract] [Full Text] [Related]
18. Unusual mid-shaft fractures during long-term bisphosphonate therapy.
Odvina CV; Levy S; Rao S; Zerwekh JE; Rao DS
Clin Endocrinol (Oxf); 2010 Feb; 72(2):161-8. PubMed ID: 19302584
[TBL] [Abstract][Full Text] [Related]
19. Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover.
Peris P; Torra M; Olivares V; Reyes R; Monegal A; Martínez-Ferrer A; Guañabens N
Bone; 2011 Oct; 49(4):706-9. PubMed ID: 21742070
[TBL] [Abstract][Full Text] [Related]
20. Paget disease of bone. Diagnosis and indications for treatment.
Kotowicz MA
Aust Fam Physician; 2004 Mar; 33(3):127-31. PubMed ID: 15054976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
